Inventor
BOSQUES CARLOS J
US37 patents
⚠️ This page may combine multiple inventors who share the name “BOSQUES CARLOS J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MOMENTA PHARMACEUTICALS INC
26 patentsUS8703498B2Apr 22, 2014
Multi-dimensional chromatographic methods for separating N-glycans
MOMENTA PHARMACEUTICALS INC19 citations92
US11623964B2Apr 11, 2023
Compositions and methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC6 citations85
US11220531B2Jan 11, 2022
Engineered Fc constructs
MOMENTA PHARMACEUTICALS INC6 citations85
US11155640B2Oct 26, 2021
Compositions and methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC6 citations82
US11124573B2Sep 21, 2021
Compositions and methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC6 citations82
US10239944B2Mar 26, 2019
Compositions and methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC13 citations82
US8361705B2Jan 29, 2013
Characterization of N-glycans using exoglycosidases
MOMENTA PHARMACEUTICALS INC14 citations82
US8043863B2Oct 25, 2011
MS methods to evaluate glycans
MOMENTA PHARMACEUTICALS INC14 citations82
US11352415B2Jun 7, 2022
Methods for the treatment of neurodegeneration
MOMENTA PHARMACEUTICALS INC4 citations81
US10464996B2Nov 5, 2019
Methods for the treatment of neurodegeneration
MOMENTA PHARMACEUTICALS INC7 citations81
US9890410B2Feb 13, 2018
N-acetylhexosamine-containing N-glycans in glycoprotein products
MOMENTA PHARMACEUTICALS INC7 citations79
US9663581B2May 30, 2017
Modified glycoproteins
MOMENTA PHARMACEUTICALS INC7 citations79
US11827682B2Nov 28, 2023
Engineered Fc constructs
MOMENTA PHARMACEUTICALS INC0 citations62
US9933432B2Apr 3, 2018
Multi-dimensional chromatographic methods for separating N-glycans
MOMENTA PHARMACEUTICALS INC1 citations62
US9448147B2Sep 20, 2016
Multi-dimensional chromatographic methods for separating N-glycans
MOMENTA PHARMACEUTICALS INC2 citations62
US12297291B2May 13, 2025
Compositions and methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC0 citations61
US12071482B2Aug 27, 2024
Compositions and methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC0 citations61
US12297256B2May 13, 2025
Methods for the treatment of neurodegeneration
MOMENTA PHARMACEUTICALS INC0 citations59
US10317410B2Jun 11, 2019
Multi-dimensional chromatographic methods for separating N-glycans
MOMENTA PHARMACEUTICALS INC0 citations51
US12391759B2Aug 19, 2025
Methods related to engineered Fc constructs
MOMENTA PHARMACEUTICALS INC0 citations50
US9029081B2May 12, 2015
Characterization of N-glycans using exoglycosidases
MOMENTA PHARMACEUTICALS INC1 citations50
US10377809B2Aug 13, 2019
Modified glycoproteins
MOMENTA PHARMACEUTICALS INC0 citations48
US10023894B2Jul 17, 2018
Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from CHO cells
MOMENTA PHARMACEUTICALS INC1 citations48
US12559542B2Feb 24, 2026
Glycoproteins with anti-inflammatory properties
MOMENTA PHARMACEUTICALS INC0 citations47
US10377832B2Aug 13, 2019
Modified glycoproteins
MOMENTA PHARMACEUTICALS INC0 citations47
US9695244B2Jul 4, 2017
Methods related to denosumab
MOMENTA PHARMACEUTICALS INC0 citations39
PARSONS IAN CHRISTOPHER
4 patentsUS8304250B2Nov 6, 2012
Multi-dimensional chromatographic methods for separating N-glycans
PARSONS IAN CHRISTOPHER22 citations91
US9182467B2Nov 10, 2015
Comparative analysis of protein conformations by using 2D NOESY NMR spectra
PARSONS IAN CHRISTOPHER16 citations82
US8216851B2Jul 10, 2012
Characterization of N-glycan mixtures by nuclear magnetic resonance
PARSONS IAN CHRISTOPHER14 citations82
US8663999B2Mar 4, 2014
Characterization of N-glycan mixtures by nuclear magnetic resonance
PARSONS IAN CHRISTOPHER14 citations79